lncRNA-PDPK2P promotes hepatocellular carcinoma progression through the PDK1/AKT/Caspase 3 pathway

Pan, WD; Li, W; Zhao, J; Huang, ZY; Zhao, JY; Chen, SX; Wang, CS; Xue, YQ; Huang, F; Fang, QN; Wang, JL; Brand, D; Zheng, SG

Pan, WD (reprint author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Hepatobiliary Surg, Guangzhou, Guangdong, Peoples R China.; Zheng, SG (reprint author), Ohio State Univ, Coll Med, Dept Internal Med, 1581 Dodd Dr, Columbus, OH 43201 USA.

MOLECULAR ONCOLOGY, 2019; 13 (10): 2246

Abstract

Hepatocellular carcinoma (HCC) is a malignancy with one of the worst prognoses. Long noncoding RNA (lncRNA) are emerging as an important regulator of ......

Full Text Link